Management of Thrombocytopenia in Teenagers

Initial Approach

For a teenager with thrombocytopenia who has no bleeding or only mild bleeding, observation alone is recommended regardless of the platelet count 1
The decision to treat should be based on bleeding severity, not platelet number alone 1

Obtain a peripheral blood smear immediately to exclude pseudothrombocytopenia (EDTA-dependent platelet clumping) 1
Perform a complete blood count with differential to confirm isolated thrombocytopenia versus pancytopenia 1

Severe bleeding occurs in only 3% of children with ITP 1
Risk of intracranial hemorrhage is approximately 0.1-0.5%, with most occurring within the first 5 weeks of diagnosis 1
Bleeding risk increases significantly when platelet count falls below 10 × 10⁹/L 1
Risk factors for serious bleeding include head trauma and concurrent use of medications affecting platelet function (aspirin, NSAIDs) 1

At platelet counts >30 × 10⁹/L with no or mild bleeding, treatment is not indicated 1, 2
Initiate treatment only if clinically significant bleeding is present, lifestyle or psychosocial factors significantly impact quality of life, or invasive procedures are planned 1, 2

Intravenous Immunoglobulin (IVIg) dose: 0.8-1 g/kg as a single dose, response rate: >80%, time to response: 1-2 days, side effects: headache, fever 2
Corticosteroids (Short Course) dose: Prednisone 1-2 mg/kg/day for maximum of 14 days, response rate: up to 75%, time to response: 2-7 days, side effects: transient mood changes, gastritis, weight gain 2
Anti-D Immunoglobulin (Rh-positive patients only) dose: 50-75 μg/kg, response rate: 50-77%, time to response: ≥50% respond within 24 hours, side effects: headache, fever, chills; hemolysis (rare) 2

Teenagers with ITP should avoid competitive contact sports with high risk of head trauma 1
Strictly avoid medications that impair platelet function: NSAIDs (ibuprofen, naproxen) 1

Weekly or less-frequent outpatient visits for stable teenagers with mild symptoms 2
Obtain complete blood counts weekly during dose adjustment phase if treatment initiated 2
Monthly monitoring following establishment of stable platelet counts 2

Approximately two-thirds of children will improve spontaneously within days to 6 months, and spontaneous remissions are generally durable 2

Do not treat based on platelet number alone—bleeding symptoms should dictate treatment decisions 1
Do not use prolonged corticosteroid therapy due to significant toxicities in adolescents 1
Do not delay evaluation for secondary causes if atypical features are present 1
Do not forget to counsel about avoiding head trauma and antiplatelet medications 1